SCHEMBL20154893

SCHEMBL20154893

Nc1ncc(-c2cccc(F)c2)c(NCCN2CCOCC2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 3/20 0.55
IRAK1 P51617 1/20 0.55
CYP1A2 P05177 6/20 0.52
CYP3A4 P08684 6/20 0.52
CYP2D6 P10635 6/20 0.52
LMNA P02545 3/20 0.52
HSD17B10 Q99714 2/20 0.52
TP53 P04637 1/20 0.52
ALOX15 P16050 1/20 0.52
HIF1A Q16665 1/20 0.52
SIGMAR1 Q99720 1/20 0.47
CCNT1 O60563 1/20 0.47
LRRK2 Q5S007 1/20 0.47
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
PIK3CG P48736 1/20 0.45
TLR9 Q9NR96 1/20 0.45
CHRM1 P11229 1/20 0.44
CNR1 P21554 1/20 0.44
ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4107195 0.94 IRAK4 (0.57) IRAK4IRAK1CYP1A2CYP3A4CYP2D6
SCHEMBL4120168 0.92 IRAK4 (0.60) IRAK4IRAK1CYP1A2CYP3A4CYP2D6
SCHEMBL4078120 0.84 ACP1 (0.52) IRAK4ADORA2AADORA1PIK3CG
SCHEMBL3971420 0.84 IRAK4 (0.58) IRAK4IRAK1CYP1A2CYP3A4CYP2D6
SCHEMBL4099481 0.84 ACP1 (0.53) IRAK4ADORA2AADORA1PIK3CGKCNH2
SCHEMBL4112500 0.83 ACP1 (0.50) IRAK4IRAK1
SCHEMBL4100258 0.83 IRAK4 (0.62) IRAK4IRAK1CYP1A2CYP3A4CYP2D6
SCHEMBL4105149 0.82 ACP1 (0.52) IRAK4IRAK1
SCHEMBL3978332 0.82 SMN1; SMN2 (0.59) IRAK4IRAK1CYP1A2CYP3A4CYP2D6
SCHEMBL3974107 0.82 IRAK4 (0.57) IRAK4IRAK1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3530656-B1 2-SUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE, AND PREPARATION AND APPLICATION THEREOF UNIV ZHEJIANG (CN) 2022-01-05 EP disclosed
US-10822327-B2 2-substituted aromatic ring-pyrimidine derivative and preparation and application thereof ZHEJIANG UNIVERSITY (CN) 2020-11-03 US disclosed
EP-3530656-A1 2-SUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE, AND PREPARATION AND APPLICATION THEREOF Zhejiang University (CN) 2019-08-28 EP disclosed
WO-2018086547-A1 2-SUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE, AND PREPARATION AND APPLICATION THEREOF 浙江大学 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10822327-B2 2-substituted aromatic ring-pyrimidine derivative and preparation and application thereof CHEK1, CHEK2, PLK1 IRAK4 839/4885IRAK1 679/4885CYP1A2 3423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.